A detailed history of Bahl & Gaynor Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bahl & Gaynor Inc holds 88,422 shares of BDX stock, worth $19.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
88,422
Previous 97,426 9.24%
Holding current value
$19.8 Million
Previous $22.8 Million 6.37%
% of portfolio
0.11%
Previous 0.13%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$221.47 - $242.41 $1.99 Million - $2.18 Million
-9,004 Reduced 9.24%
88,422 $21.3 Million
Q2 2024

Aug 07, 2024

SELL
$225.07 - $246.17 $1.46 Million - $1.59 Million
-6,472 Reduced 6.23%
97,426 $22.8 Million
Q1 2024

May 10, 2024

SELL
$233.45 - $247.73 $758,245 - $804,627
-3,248 Reduced 3.03%
103,898 $25.7 Million
Q4 2023

Feb 02, 2024

SELL
$232.24 - $267.23 $216,215 - $248,791
-931 Reduced 0.86%
107,146 $26.1 Million
Q3 2023

Nov 03, 2023

BUY
$254.9 - $283.59 $203,155 - $226,021
797 Added 0.74%
108,077 $27.9 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $677,742 - $754,304
-2,843 Reduced 2.58%
107,280 $28.3 Million
Q1 2023

May 03, 2023

BUY
$229.71 - $259.35 $56,508 - $63,800
246 Added 0.22%
110,123 $27.3 Million
Q4 2022

Feb 10, 2023

SELL
$218.29 - $256.91 $255,617 - $300,841
-1,171 Reduced 1.05%
109,877 $28 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $67,257 - $348,255
-1,318 Reduced 1.17%
111,048 $24.7 Million
Q2 2022

Aug 08, 2022

SELL
$234.74 - $275.42 $653,750 - $767,044
-2,785 Reduced 2.42%
112,366 $27.7 Million
Q1 2022

May 12, 2022

SELL
$243.64 - $270.48 $650,275 - $721,911
-2,669 Reduced 2.27%
115,151 $30.6 Million
Q4 2021

Feb 10, 2022

SELL
$230.08 - $250.94 $424,957 - $463,486
-1,847 Reduced 1.54%
117,820 $29.6 Million
Q3 2021

Nov 15, 2021

SELL
$232.72 - $256.47 $453,571 - $499,860
-1,949 Reduced 1.6%
119,667 $29.4 Million
Q2 2021

Aug 06, 2021

SELL
$232.65 - $254.58 $1.29 Million - $1.42 Million
-5,563 Reduced 4.37%
121,616 $29.6 Million
Q1 2021

May 11, 2021

SELL
$232.09 - $256.88 $523,362 - $579,264
-2,255 Reduced 1.74%
127,179 $30.9 Million
Q4 2020

Feb 02, 2021

SELL
$221.92 - $245.94 $371,716 - $411,949
-1,675 Reduced 1.28%
129,434 $32.4 Million
Q3 2020

Nov 12, 2020

SELL
$215.77 - $276.76 $2.11 Million - $2.7 Million
-9,771 Reduced 6.94%
131,109 $30.5 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $702,580 - $841,594
-3,195 Reduced 2.22%
140,880 $33.7 Million
Q1 2020

May 26, 2020

BUY
$195.69 - $279.01 $28.2 Million - $40.2 Million
144,075 New
144,075 $33.1 Million
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $29.4 Million - $42 Million
-150,448 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$236.45 - $266.82 $670,335 - $756,434
-2,835 Reduced 1.85%
150,448 $40.9 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $7.1 Million - $7.89 Million
-30,804 Reduced 16.73%
153,283 $38.8 Million
Q2 2019

Aug 12, 2019

SELL
$217.4 - $246.08 $1.26 Million - $1.43 Million
-5,791 Reduced 3.05%
184,087 $46.4 Million
Q1 2019

May 13, 2019

SELL
$206.05 - $248.17 $9.72 Million - $11.7 Million
-47,173 Reduced 19.9%
189,878 $47.4 Million
Q4 2018

Feb 12, 2019

BUY
$204.73 - $257.93 $5.69 Million - $7.17 Million
27,788 Added 13.28%
237,051 $53.4 Million
Q3 2018

Nov 09, 2018

SELL
$233.07 - $256.0 $7.71 Million - $8.47 Million
-33,087 Reduced 13.65%
209,263 $54.6 Million
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $457,195 - $513,768
2,197 Added 0.91%
242,350 $58.1 Million
Q1 2018

May 11, 2018

SELL
$205.46 - $240.27 $736,368 - $861,127
-3,584 Reduced 1.47%
240,153 $52 Million
Q4 2017

Feb 13, 2018

SELL
$189.0 - $222.64 $421,659 - $496,709
-2,231 Reduced 0.91%
243,737 $52.2 Million
Q3 2017

Nov 13, 2017

SELL
$186.89 - $198.9 $679,532 - $723,200
-3,636 Reduced 1.46%
245,968 $48.2 Million
Q2 2017

Aug 11, 2017

SELL
N/A
-1,135 Reduced 0.45%
249,604 $48.7 Million
Q2 2017

Aug 10, 2017

BUY
N/A
250,739
250,739 $41.5 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.